πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 401 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8007787

Human cystathionine Ξ²-synthase variants and methods of production thereof

The Regents of the University of Colorado Β· Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8007804

Complement receptor 2 targeted complement modulators

The Regents of the University of Colorado Β· Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999082

Anti-factor B antibodies

The Regents of the University of Colorado Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7993648

Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD

The Regents of the University of Colorado Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7976851

Non-toxic biofilm inhibitor

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915285

Method for treating drug and behavioral addictions

The Regents of the University of Colorado Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7862811

Protease inhibition for prevention or treatment of heart failure

The Regents of the University of Colorado Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858349

Anti-cancer compounds

The Regents of the University of Colorado Β· Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7850970

Inhibitors of serine protease activity and their use in methods and compositions for treat

The Regents of the University of Colorado Β· Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7838571

Photopolymers and use in dental restorative materials

The Regents of the University of Colorado Β· Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7807781

Inhibitors of serine protease activity and their use in methods and compositions for treat

The Regents of the University of Colorado Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763259

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus in

The Regents of the University of Colorado Β· Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759304

Targeting complement factor H for treatment of diseases

The Regents of the University of Colorado Β· Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7750121

Antibody to telomerase reverse transcriptive

The Regents of the University of Colorado Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749490

Mutant IL-10

The Regents of the University of Colorado Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678824

Methods for treatment with bucindolol based on genetic targeting

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622549

Human telomerase reverse transcriptase polypeptides

The Regents of the University of Colorado Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7595060

Yeast-antigen compositions methods of making the same

The Regents of the University of Colorado Β· Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585622

Increasing the proliferative capacity of cells using telomerase reverse transcriptase

The Regents of the University of Colorado Β· Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560437

Nucleic acid compositions for eliciting an immune response against telomerase reverse tran

The Regents of the University of Colorado Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560265

Compositions for regulation of tumor necrosis factor-alpha

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517971

Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity

The Regents of the University of Colorado Β· Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7510710

Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a g

The Regents of the University of Colorado Β· Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7485307

Human cystathionine Ξ²-synthase variants and methods of production thereof

The Regents of the University of Colorado Β· Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted